Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced toxic myocarditis.

Azam Ansari1, Barry J Maron, Daniel G Berntson

  • 1The Department of Cardiovascular Medicine, Fairview Southdale Hospital, Edina, Minnesota, USA. dr_azam_ansari@hotmail.com

Texas Heart Institute Journal
|March 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease.

Journal of the American College of Cardiology·2023
Same author

Commotio Cordis Returns…When We Least Expected It: Cardiac Arrest in A Professional Football Player.

The American journal of cardiology·2023
Same author

Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective.

Journal of the American College of Cardiology·2023
Same author

Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field?

The American journal of cardiology·2023
Same author

Clinical Significance of Postoperative Atrial Fibrillation in Hypertrophic Cardiomyopathy Patients Undergoing Septal Myectomy.

The Canadian journal of cardiology·2023
Same author

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?

Journal of the American Heart Association·2023
Same journal

Lyme Carditis and Inflammation-Driven Plaque Erosion Presenting as Sudden Cardiac Arrest.

Texas Heart Institute journal·2025
Same journal

Risk Factors for Development of Stroke in Patients With Continuous-Flow Left Ventricular Assist Device Support as Destination Therapy.

Texas Heart Institute journal·2025
Same journal

Midterm Outcomes of Pediatric Mitral Valvuloplasty for Moderate to Severe Mitral Valve Regurgitation and Associated Risk Factors for Postoperative Deterioration.

Texas Heart Institute journal·2025
Same journal

Navigating the Complexities of Mitral Valve Clipping: Early Severe Mitral Valve Stenosis After Mitral Valve Clipping.

Texas Heart Institute journal·2025
Same journal

The Department of Cardiovascular Anesthesia of The Texas Heart Institute: An Informal History.

Texas Heart Institute journal·2025
Same journal

Contributions of Pathobiological and Translational Science to Understanding and Managing Ischemic Heart Disease: Progress, Impediments, and Future Directions.

Texas Heart Institute journal·2025
See all related articles

A woman developed severe heart failure and dilated cardiomyopathy, likely due to psychiatric medications. Autopsy revealed toxic myocarditis, highlighting potential drug-induced cardiac toxicity.

Area of Science:

  • Cardiology
  • Psychopharmacology
  • Toxicology

Background:

  • A 66-year-old woman with chronic paranoid schizophrenia developed new-onset complete left bundle branch block and congestive heart failure.
  • She had been on psychiatric medications for 10 years to manage her condition.

Observation:

  • Echocardiogram revealed dilated cardiomyopathy with severely impaired left ventricular function (ejection fraction <0.25).
  • Despite discontinuing perphenazine and amitriptyline, the patient's condition progressed.

Findings:

  • The patient died from refractory congestive heart failure two years after presentation.
  • Autopsy showed persistent toxic myocarditis with cardiac fibrosis and chronic hepatitis, considered drug-related.

Implications:

Related Experiment Videos

  • This case underscores the potential for certain psychotropic medications to cause severe, persistent cardiac damage.
  • Highlights the importance of monitoring cardiac function in patients on long-term psychotropic drug therapy.
  • Suggests a need for further research into the cardiotoxic mechanisms of specific psychotropic agents.